Pfizer asked the FDA to authorize its Covid-19 booster dose for children 5 to 11 years old. The agency is expected to take a couple of weeks to conduct its review, a person familiar with the matter said. https://on.wsj.com/37Ey7KZ
@WSJ3 years ago
Regulatory clearance of the Pfizer-BioNTech Covid-19 vaccine for young children may not come until November, according to a person familiar with the matter https://on.wsj.com/39N56Kc
@BBCWorld4 years ago
“The vaccine will be distributed to frontline workers, the elderly and high-risk Americans… in a matter of weeks” President Trump gives an update on the Pfizer Covid-19 vaccine and says it will be available to the entire general population in April http://bbc.in/3nzKiuT https://t.co/45QeBY3waZ
@politico.com3 years ago
Pfizer, BioNTech ask FDA to authorize Covid-19 vaccine for kids 5-11
@rt.com3 years ago
Pfizer booster will likely be approved by Sep. 20, Fauci says after claiming further doses needed to be ‘fully vaccinated’
@forbes.com4 years ago
Stocks Soar On Vaccine News
@rt.com3 years ago
Pfizer sends Covid vaccine data for kids aged 5-11 to FDA as Fauci hopes to start child vaccinations by end of October
@forbes.com4 years ago
What The FDA’s Approval Of The Pfizer Coronavirus Vaccine Means For Workers
@abcnews.go.com4 years ago
Pfizer may win the COVID vaccine race. But distributing it could be another matter.
@WSJ3 years ago
Regulatory clearance of the Pfizer-BioNTech Covid-19 vaccine for young children may not come until November, according to a person familiar with the matter https://on.wsj.com/3kOHivP
@vox.com4 years ago
7 questions about Covid-19 booster shots, answered
@abcnews.go.com4 years ago
Pfizer may win the COVID vaccine race. But distributing it could be another matter.
